McMahon Score for Rhabdomyolysis
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–5.9
- Not Low Risk6–20
The McMahon Score for Rhabdomyolysis calculates predicting mortality or acute kidney injury (AKI) requiring renal replacement therapy in hospitalized rhabdomyolysis patients. Key inputs include age. Scores guide adjusting renal medication clearance, coordinating nephrology follow-up, or planning renal replacement therapy. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Predicts mortality or acute kidney injury (AKI) requiring renal replacement therapy in hospitalized rhabdomyolysis patients. The score helps identify low-risk patients unlikely to have severe adverse outcomes.
Clinical Indication
The McMahon Score for Rhabdomyolysis is indicated for bedside clinical practice to support Predicts mortality or acute kidney injury (AKI) requiring renal replacement therapy in hospitalized rhabdomyolysis patients. The score helps identify low-risk patients unlikely to have severe adverse outcomes.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with acute kidney injury (AKI), chronic kidney disease stages 1-5, or acid-base and fluid-electrolyte disturbances. Clinical application is indicated across Nephrology clinics, hemodialysis units, acute inpatient renal services, and metabolic wards.
Limitations & Contraindications
eGFR estimation equations assume steady-state serum creatinine and become unreliable during unstable AKI, amputations, or extremes of muscle mass.
Clinical Pearls & Action Plan
Serum creatinine lags behind acute reductions in glomerular filtration; monitor hourly urine output and consider cystatin C in evolving AKI.
Score = (Age points) + (Sex points) + (Initial Creatinine points) + (Initial Calcium <7.5 mg/dL points) + (Initial CPK >40,000 U/L points) + (Rhabdo Cause points) + (Initial Phosphate points) + (Initial Bicarbonate <19 mEq/L points)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age | string | Yes | Patient age category |
| sex | string | Yes | Patient biological sex |
| initial_creatinine | string | Yes | Initial serum creatinine level(mg/dL) |
| initial_calcium_low | string | Yes | Initial calcium less than 7.5 mg/dL |
| initial_cpk_high | string | Yes | Initial creatine phosphokinase (CPK) greater than 40,000 U/L |
| rhabdo_cause | string | Yes | Rhabdomyolysis secondary cause |
| initial_phosphate | string | Yes | Initial phosphate level(mg/dL) |
| initial_bicarbonate_low | string | Yes | Initial bicarbonate less than 19 mEq/L |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–5.9 | Low Risk | Low risk for death or AKI requiring RRT |
| 6–20 | Not Low Risk | Not low risk for adverse outcomes |
Evidence-Based References (EBM)
- McMahon GM, Zeng X, Waikar SS. A risk prediction score for kidney failure or mortality in rhabdomyolysis. JAMA Intern Med. 2013 Oct 28;173(19):1821-8. doi: 10.1001/jamainternmed.2013.9774.DOI: 10.1001/jamainternmed.2013.9774
- Safari S, Yousefifard M, Hashemi B, Baratloo A, Forouzanfar MM, Rahmati F, et al. The value of serum creatine kinase in predicting the risk of rhabdomyolysis-induced acute kidney injury: a systematic review and meta-analysis. Clin Exp Nephrol. 2016 Apr;20(2):153-61. doi: 10.1007/s10157-015-1204-1.DOI: 10.1007/s10157-015-1204-1
- Premru V, Kovač J, Buturović-Ponikvar J, Ponikvar R. Some kinetic considerations in the treatment of acute kidney injury caused by rhabdomyolysis. Ther Apher Dial. 2017 Oct;21(5):451-456. doi: 10.1111/1744-9987.12547.DOI: 10.1111/1744-9987.12547